107 studies found for:    Open Studies | "Peritoneal Diseases"
Show Display Options
Rank Status Study
21 Recruiting Treatment of Splanchnic Vein Thrombosis With Rivaroxaban. A Pilot, Prospective Cohort Study
Conditions: Portal Vein Thrombosis;   Mesenteric Vein Thrombosis;   Splenic Vein Thrombosis
Intervention: Drug: rivaroxaban
22 Recruiting Evaluation of Serum-Derived Bovine Immunoglobulin Protein Isolate in Subjects With Decompensated Cirrhosis With Ascites
Conditions: Cirrhosis of the Liver;   Ascites;   Spontaneous Bacterial Peritonitis
Intervention: Other: Medical food, EnteraGam (Serum-Derived Bovine Immunoglobulin)
23 Recruiting Study of IMGN853 in Comb. With Bevacizumab, Carboplatin or PLD in Adults With FRa + Adv. EOC, Primary Peritoneal, Fallopian Tube, or Endometrial Cancer
Conditions: Epithelial Ovarian Cancer;   Primary Peritoneal Cancer;   Fallopian Tube Cancer;   Endometrial Cancer
Interventions: Drug: IMGN853;   Drug: Bevacizumab;   Drug: Carboplatin;   Drug: Doxorubicin
24 Not yet recruiting Impacts of Different Pressure Pneumoperitoneum on Myocardial and Pulmonary Injuries After Robot-assisted Surgery
Conditions: Prostatic Neoplasms;   Urinary Bladder Neoplasms
Interventions: Procedure: low-pressure pneumoperitoneum;   Procedure: standard-pressure pneumoperitoneum
25 Recruiting Palliative Care in Improving Quality of Life in Patients With High Risk Primary or Recurrent Gynecologic Malignancies
Conditions: Cervical Carcinoma;   Ovarian Carcinoma;   Primary Peritoneal Carcinoma;   Recurrent Cervical Carcinoma;   Recurrent Ovarian Carcinoma;   Recurrent Uterine Corpus Carcinoma;   Recurrent Vulvar Carcinoma;   Uterine Corpus Cancer;   Vulvar Carcinoma;   Peritoneal Neoplasms
Interventions: Other: Palliative Therapy;   Other: Palliative Therapy + idiographic
26 Recruiting Safety and Efficacy of CRS-207 With Epacadostat in Platinum Resistant Ovarian, Fallopian, or Peritoneal Cancer
Conditions: Platinum-resistant Ovarian Cancer;   Platinum-resistant Fallopian Cancer;   Platinum-resistant Peritoneal Cancer
Interventions: Biological: CRS-207;   Drug: epacadostat (INCB024360)
27 Recruiting PARP-inhibition and CTLA-4 Blockade in BRCA-deficient Ovarian Cancer
Conditions: Ovarian Cancer;   Fallopian Tube Cancer;   Peritoneal Neoplasms
Interventions: Drug: Olaparib;   Drug: Tremelimumab
28 Recruiting Study of the Effect of Adjunctive Vivomixx® in Patients With Cirrhosis and Spontaneous Bacterial Peritonitis (SBP)
Condition: Spontaneous Bacterial Peritonitis
Interventions: Drug: Vivomixx®;   Drug: Placebo
29 Recruiting Pneumoperitoneum Management With SurgiQuest AirSeal at Low vs. Higher Pressure ( PRESSURE )
Condition: Shoulder Pain
Intervention: Device: SurgiQuest AIRSEAL® Insufflation System (AIS)
30 Recruiting Study of Prolanta™ in Recurrent or Persistent Epithelial Ovarian Cancer
Conditions: Ovarian Cancer;   Peritoneal Cancer;   Fallopian Tube Cancer
Intervention: Biological: Prolanta, a human prolactin receptor antagonist
31 Not yet recruiting Epigenetic Determinants of Peritoneal Fibrosis
Condition: Peritoneal Fibrosis
Intervention:
32 Recruiting Cyclophosphamide Followed by Intravenous and Intraperitoneal Infusion of Autologous T Cells Genetically Engineered to Secrete IL-12 and to Target the MUC16ecto Antigen in Patients With Recurrent MUC16ecto+ Epithelial Ovarian, Fallopian Tube or Primary Peritoneal Cancer
Conditions: High Grade Serous Ovarian Cancer;   Primary Peritoneal Cancer;   Fallopian Tube Cancer
Interventions: Procedure: Production of Genetically-modified T cells;   Drug: Cyclophosphamide;   Device: IP Catheter Insertion;   Genetic: Infusion of 4H11-28z/fIL-12/EFGRt+ Genetically-modified T cells
33 Recruiting Study of Safety & Biological Activity of IP GEN-1 With Neoadjuvant Chemo in Ovarian Cancer
Conditions: Epithelial Ovarian Cancer;   Fallopian Tube Cancer;   Primary Peritoneal Cancer
Intervention: Biological: GEN-1
34 Not yet recruiting DNA Single Nucleotide Polymorphisms as Predictors of Toxicity
Conditions: Ovarian Neoplasms;   Fallopian Tube Neoplasms;   Peritoneal Neoplasms
Intervention:
35 Recruiting To Compare the Efficacy of Carbepenem Versus Carbepenem Plus GM-CSF in Difficult To Treat Spontaneous Bacterial Peritonitis
Condition: Spontaneous Bacterial Peritonitis
Interventions: Drug: Carbepenem;   Drug: Albumin;   Drug: GMCSF (of Granulocyte-Monocyte Colony-Stimulating Factor) .
36 Recruiting Identification of Ascitic Fluid Bacterial Pathogens in Spontaneous Bacterial Peritonitis
Condition: Primary Bacterial Peritonitis
Intervention: Other: ascitic fluid culture and microbiological testing
37 Recruiting Is Spontaneous Bacterial Peritonitis Still Responding to 3rd Generation Cephalosporins?
Condition: Primary Bacterial Peritonitis
Interventions: Drug: Cefotaxime;   Drug: ceftriaxone
38 Not yet recruiting p53 Gene in Treatment of Recurrent Ovarian Epithelial Cancer, Fallopian Tube Cancer, and Primary Peritoneal Cancer
Conditions: Ovarian Epithelial Cancer;   Fallopian Tube Cancer;   Primary Peritoneal Cancer
Interventions: Drug: p53 gene;   Drug: Cisplatin;   Drug: Paclitaxel
39 Recruiting Consumer-Based Activity Monitor in Evaluating and Measuring Activity of Older Patients With Abdominal Cancer Undergoing Surgery
Conditions: Malignant Gastrointestinal Neoplasm;   Malignant Peritoneal Neoplasm
Interventions: Device: Management of Therapy Complications Fitbit Zip (portable pedometer device);   Other: Questionnaire Administration;   Other: Quality-of-Life Assessment
40 Recruiting PROPHYlactic Implantation of BIOlogic Mesh in Peritonitis (PROPHYBIOM)
Condition: Incisional Hernia
Interventions: Device: Biological swine dermis not cross-linked prosthesis positioning in incisional hernia prevention;   Procedure: Direct suture of the anterior abdominal wall fascia

First Page    Show previous page of results Previous Page (1-20) Studies Shown (21-40) Next Page (41-60) Show next page of results    Last Page
Indicates status has not been verified in more than two years